id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0079-0008,FDA,FDA-2011-N-0079,New Animal Drugs for Investigational Use; Disqualification of a Clinical Investigator,Rule,Final Rule,2017-12-28T05:00:00Z,2017,12,2017-12-28T05:00:00Z,,2017-12-28T15:16:14Z,2017-27973,0,0,0900006482d7abb6
FDA-2011-N-0079-0006,FDA,FDA-2011-N-0079,Disqualification of a Clinical Investigator,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2016-08-24T04:00:00Z,2016,8,2016-08-24T04:00:00Z,2016-11-23T04:59:59Z,2016-08-26T01:01:20Z,2016-19876,0,0,0900006482197a70
FDA-2011-N-0079-0005,FDA,FDA-2011-N-0079,Disqualification of a Clinical Investigator,Rule,Final Rule,2012-05-01T04:00:00Z,2012,5,2012-05-01T04:00:00Z,,2012-05-01T14:34:28Z,2012-10292,0,0,09000064810020ec
FDA-2011-N-0079-0004,FDA,FDA-2011-N-0079,Disqualification of a Clinical Investigator,Rule,,2012-04-30T00:00:00Z,2012,4,,,2012-05-01T13:04:13Z,,0,1,090000648100077d
FDA-2011-N-0079-0001,FDA,FDA-2011-N-0079,Disqualification of a Clinical Investigator,Proposed Rule,NPR-Notice of Proposed Rule-Making,2011-04-13T04:00:00Z,2011,4,2011-04-13T04:00:00Z,2011-07-13T03:59:59Z,2011-06-11T16:30:42Z,2011-08786,0,0,0900006480c25e36